Alkem Laboratories Ltd (ALKE)

BSE


	Symbol		Exchange		Currency
	ALKE		NSE		INR	Real-time
	ALKEc1:NS		NSE		INR	Delayed
	ALKE		BSE		INR	Delayed

Currency in INR

5,140.90

-10.60(-0.21%)

Delayed Data09:17:31

Fair Value

Day's Range

5,114.75

5,179.00

52 wk Range

4,409.90

6,440.00

ALKE Income Statement

Featured here, the Income Statement (earnings report) for Alkem Laboratories Ltd, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Advanced Income Statement

<

Period Ending:

2015

31/03

2016

31/03

2017

31/03

2018

31/03

2019

31/03

2020

31/03

2021

31/03

2022

31/03

2023

31/03

2024

31/03

Total Revenues

83,443.6

88,650.1

106,341.9

115,992.6

126,675.8

Total Revenues Growth

+13.42%

+6.24%

+19.96%

+9.08%

+9.21%

Cost Of Revenues

34,232.9

35,751.1

42,806.4

50,207.3

50,641.5

Gross Profit

49,210.7

52,899

63,535.5

65,785.3

76,034.3

Gross Profit Growth

+13.4%

+7.49%

+20.11%

+3.54%

+15.58%

Gross Profit Margin %

58.97%

59.67%

59.75%

56.72%

60.02%

Other Operating Expenses, Total

36,550.5

36,159.7

46,103.4

52,589.4

56,358.8

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+7.57%	-1.07%	+27.5%	+14.07%	+7.17%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	20,852.6	19,807.2	25,769	29,726	30,329.2
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	13,180.2	13,616.5	17,304.7	19,759.8	23,041.4

Operating Income

12,660.2

16,739.3

17,432.1

13,195.9

19,675.5

Operating Income Growth

+34.44%

+32.22%

+4.14%

-24.3%

+49.1%

EBIT Margin %

15.17%

18.88%

16.39%

11.38%

15.53%

Net Interest Expenses

166.2

502.5

917.9

902.2

1,953.9

Net Interest Expenses Growth

+1,313.14%

+202.35%

+82.67%

-1.71%

+116.57%

Interest Expense, Total

-466.1

-398.7

-308.9

-809.2

-803.8

Interest And Investment Income

632.3

901.2

1,226.8

1,711.4

2,757.7

Other Non Operating Expenses, Total

-37.1

421.7

-40.7

-201.4

-322.9

EBT, Excl. Unusual Items

12,789.3

17,663.5

18,309.3

13,896.7

21,306.5

Gain (Loss) On Sale Of Assets

12.7

388

19.7

-123.6

-31.8

Other Unusual Items, Total

-32.7

-

-0.7

-1,034

-1,195.1

EBT, Incl. Unusual Items

12,597.9

18,421

18,442.8

13,047.7

20,231.3

EBT, Incl. Unusual Items Growth

+31.96%

+46.22%

+0.12%

-29.25%

+55.06%

EBT, Incl. Unusual Items Margin

15.1%

20.78%

17.34%

11.25%

15.97%

Income Tax Expense

1,104.8

2,243.3

1,639.6

2,979.6

2,116.7

Net Income to Company

11,493.1

16,177.7

16,803.2

10,068.1

18,114.6

Minority Interest

-222.4

-327.5

-347

-226.4

-156.9

Net Income

11,270.7

15,850.2

16,456.2

9,841.7

17,957.7

Net Income Growth

+48.2%

+40.63%

+3.82%

-40.19%

+82.47%

Net Income Margin %

13.51%

17.88%

15.47%

8.48%

14.18%

Preferred Dividend and Other Adjustments

-

-

-

-

-

Net Income to Common Excl. Extra Items

11,270.7

15,850.2

16,456.2

9,841.7

17,957.7

Basic EPS - Continuing Operations

94.26

132.57

137.63

82.31

150.19

Basic EPS - Continuing Operations Growth

+48.2%

+40.63%

+3.82%

-40.19%

+82.47%

Diluted EPS - Continuing Operations

94.26

132.57

137.63

82.31

150.19

Diluted EPS - Continuing Operations Growth

+48.2%

+40.63%

+3.82%

-40.19%

+82.47%

Basic Weighted Average Shares Outstanding

119.57

119.57

119.57

119.57

119.57

Diluted Weighted Average Shares Outstanding

119.57

119.57

119.57

119.57

119.57

Dividend Per Share

25

30

34

25

40

Dividend Per Share Growth

+56.25%

+20%

+13.33%

-26.47%

+60%

EBITDA

14,858.1

19,146.9

20,121.8

15,893.1

22,267.9

EBITDA Growth

+31.85%

+28.87%

+5.09%

-21.02%

+40.11%

EBITDA Margin %

17.81%

21.6%

18.92%

13.7%

17.58%

EBIT